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Abstract
Direct molecular imaging of nano-spatial relationship between T cell receptor (TCR)/CD3 and CD4 or CD8 co-receptor before
and after activation of a primary T cell has not been reported. We have recently innovated application of near-field scanning
optical microscopy (NSOM) and immune-labeling quantum dots (QD) to image Ag-specific TCR response during in vivo
clonal expansion, and now up-graded the NSOM/QD-based nanotechnology through dipole-polarization and dual-color
imaging. Using this imaging system scanning cell-membrane molecules at a best-optical lateral resolution, we
demonstrated that CD3, CD4 or CD8 molecules were distinctly distributed as single QD-bound molecules or nano-clusters
equivalent to 2–4 QD fluorescence-intensity/size on cell-membrane of un-stimulated primary T cells, and ,6–10% of CD3
were co-clustering with CD4 or CD8 as 70–110 nm nano-clusters without forming nano-domains. The ligation of TCR/CD3
on CD4 or CD8 T cells led to CD3 nanoscale co-clustering or interaction with CD4 or CD8 co-receptors forming 200–500 nm
nano-domains or .500 nm micro-domains. Such nano-spatial co-clustering of CD3 and CD4 or CD3 and CD8 appeared to
be an intrinsic event of TCR/CD3 ligation, not purely limited to MHC engagement, and be driven by Lck phosphorylation.
Importantly, CD28 co-stimulation remarkably enhanced TCR/CD3 nanoscale co-clustering or interaction with CD4 co-
receptor within nano- or micro-domains on the membrane. In contrast, CD28 co-stimulation did not enhance CD8 clustering
or CD3–CD8 co-clustering in nano-domains although it increased molecular number and density of CD3 clustering in the
enlarged nano-domains. These nanoscale findings provide new insights into TCR/CD3 interaction with CD4 or CD8 co-
receptor in T-cell activation.
Citation: Zhong L, Zeng G, Lu X, Wang RC, Gong G, et al. (2009) NSOM/QD-Based Direct Visualization of CD3-Induced and CD28-Enhanced Nanospatial
Coclustering of TCR and Coreceptor in Nanodomains in T Cell Activation. PLoS ONE 4(6): e5945. doi:10.1371/journal.pone.0005945
Editor: Derya Unutmaz, New York University School of Medicine, United States of America
Received February 21, 2009; Accepted May 21, 2009; Published June 17, 2009
Copyright:  2009 Zhong et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institutes of Health R01 grants: HL64560 (to ZWC), RR13601 (to ZWC), and U01 grant: AI070426 (to ZWC). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: zchen@uic.edu
. These authors contributed equally to this work.
Introduction
While T cell receptors (TCR) recognize major histocompatibil-
ity complex (MHC)-associated peptide complex (MHCp) [1,2,3,4],
CD4 or CD8 co-receptor increases the sensitivity of TCR
recognition and thus facilitates TCR/CD3-mediated signaling
and T cell activation [5,6,7,8]. The enhanced TCR recognition of
MHCp is attributed to the ability of CD4 or CD8 co-receptor to
bind to non-polymorphic regions of MHC I or II molecule, and
facilitate TCR-MHCp interaction [6,9,10]. On the other hand,
CD4 or CD8 is associated with the kinase Lck, thus CD4 or CD8
binding to MHC recruits Lck close to the TCR/CD3 and helps to
phosphorylate TCR/CD3 complex for initiation of CD3-induced
T cell signaling and activation [5]. However, precise mechanisms
by which interaction between TCR/CD3 and CD4 or CD8 co-
receptor is sustained and regulated are poorly understood.
Direct molecular imaging of nano-spatial relationship between
TCR/CD3 and CD4 or CD8 co-receptor on a primary T cell has
not been reported. Scanning fluorescence nanoscale visualization
of each of these molecules on cell-surface of CD4 or CD8 T cells is
indeed lacking. Early studies of TCR/CD3-CD4 co-localization
or interaction using conventional techniques such as flow
cytometry, fluorescence/confocal microscopy or indirect biochem-
istry analyses of membrane rafts appear to be inconclusive with
conflicting results [11,12,13,14]. Although recent studies using
microscopy fluorescence resonance energy transfer (FRET) have
demonstrated that MHCp engagement of TCR on transfected T
hybridoma cells can induce TCR/CD3 interaction (proximity)
with CD4 or CD8 co-receptor in the immunologic synapse
[15,16], a sustained interaction between TCR/CD3 and co-
receptor for achieving or maintaining full T-cell activation has not
been directly imaged at nanoscale. In this context, it is not known
whether the TCR/CD3-CD4 (CD8) interaction as demonstrated
by the FRET can also be the intrinsic capability of the TCR/CD3
activation pathway, not purely limited to the MHC engagement.
Such intrinsic capability of TCR/CD3 to recruit CD4 or CD8 co-
receptor would implicate a positive-feedback or self-enhancing
mechanism since strengthening CD3-CD4 interaction upon
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tion and sustain down-stream signaling/activation. Furthermore,
the possibility that CD28 co-signaling can enhance potential
TCR/CD3 interaction with CD4 co-receptor for full T cell
activation has not been addressed, although CD28 co-stimulation
has been shown to potentiate T cell activation
[15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]. We
presume that these fundamental questions can be addressed using
a best-optical-resolution nanoscale imaging system for direct
molecular visualization of TCR/CD3 interaction with CD4 or
CD8 co-receptor during T cell activation.
We have recently innovated the use of near-field scanning
optical microscopy [NSOM [17,18,19,20,21,22]] and quantum
dots [QD [23]] for nanoscale imaging of antigen-specific TCR
molecules on T-cell surface [24]. Our novel NSOM/QD-based
nanoscale imaging [24,25,26,27] overcomes the outstanding
problem of photobleaching conventional immune-fluorochromes
[28,29,30] while executing near-field imaging that breaks-through
the diffraction limit, and provides highly-reproducible fluorescence
imaging with a best optical resolution of ,50 nm. In fact, our
NSOM/QD-based nanoscale fluorescence imaging clearly reveals
that single-QD-bound TCR undergo nano-spatial re-distribution
to array and form high-density TCR nanoclusters or nanodomains
during an in vivo clonal expansion [24]. In the current study, we
have up-graded the NSOM/QD-based nanotechnology through
dipole-polarization and dual-color imaging to visualize nanoscale
profiles for distribution and organization of CD3, CD4 or CD8, as
well as nano-spatial relationship between CD3 and CD4 or CD8
on cell-membrane. The NSOM/QD-based imaging also demon-
strates that TCR/CD3 activation can intrinsically induce
nanoscale CD3 co-clustering or interaction with CD4 or CD8
co-receptors, which forms 200–500 nm nano-domains or
.500 nm micro-domains. More importantly, the NSOM/QD-
based imaging shows that CD28 co-stimulation can remarkably
enhance TCR/CD3 nanoscale co-clustering or interaction with
CD4, but not CD8, co-receptor within nano- or micro-domains on
the membrane.
Results
CD3, CD4 or CD8 molecules were distinctly distributed as
single QD-bound molecules or nano-clusters on cell-
membrane of un-stimulated primary T cells
As an initial effort to directly visualize TCR/CD3 co-clustering
or interaction with CD4 or CD8 co-receptor during T cell
activation, we first imaged nanoscale distribution or relationship of
each of these molecules on cell-surface of un-stimulated primary T
cells using the NSOM/QD-based polarized imaging system. This
polarized imaging system simultaneously collects two polarization
components of images [0u and 90u polarization components, [25]].
The polarized detection of one QD as we previously published
[25] allowed us to judge single or multiple QD-bound CD3, CD4
or CD8 molecules on cell-membrane. To facilitate evaluation of
nano-spatial distribution and organization of CD3, CD4 or CD8,
nanostructures of these molecules were defined based on the nano-
concept and immune-fluorescence dot sizes of them: (i) nanoclus-
ters, #200 nm, (ii) nano-domains, .200 but ,500 nm, and (iii)
micro-domains, $500, as we recently described [24]. Interestingly,
on cell-surface of un-stimulated CD4 or CD8 T cells, ,5–8% of
CD3 were single QD-bound molecules (Supporting information,
Figure S1Ai, Figure S1Aii); most of CD3 molecules were detected
as nano-clusters equivalent to 2–4 QD fluorescence-intensity and
size (i.e. full width at half maximum (FWHM)) (Supporting
information, Figure S1Aii). However, these fluorescence QD dots
representing potential monomers, dimers/multimers, or pre-
clustering of CD3/TCR [31] were clearly distinct with $40–
50 nm distance from each other under the high-resolution
NSOM. Like CD3 molecules, CD4 or CD8 co-receptors were
similarly distributed on cell-surface of un-stimulated T cells
(Supporting information, Figure S1B, Figure S1C), although more
single QD-bound CD8 co-receptors were seen on the membrane
than CD3 and CD4. It was noteworthy that no significant
fluorescence was observed when T cells were stained with control
isotype Ab followed by conjugated QD, or QD only (Figure S1D),
or isotype Ab only (Figure S1E), suggesting the specificity of the
antibody and QD staining.
We then utilized the NSOM/QD-based dual-color nanoscale
imaging system to visualize nano-spatial relationship between CD3
and CD4 or CD8 on cell-membrane of un-stimulated primary T
cells. Most of detectable CD3 were distributed distinctly ($40–
50 nm distance) away from CD4 or CD8 co-receptor on
membrane of CD4 or CD8 T cells (Fig. 1A, 1B). Interestingly,
about 6–10% of CD3 co-localized with CD4 or CD8 as ,70–
110 nm nanoclusters on cell-surface of un-stimulated T cells
(Fig. 1A, 1B, Figure S2A, Figure S2B, Figure S2C, Figure S2D).
However, these co-localized CD3 and CD4 or CD8 remained
individually distinct without forming any advanced nanostructures
such as nano-domains (Fig. 1A, 1B). Thus, the NSOM/QD-based
nanoscale imaging studies of un-stimulated primary T cells
demonstrated for the first time that even without MHCp
stimulation or TCR ligation, small numbers of CD3 co-localized
with CD4 or CD8 as 70–110 nm nanoclusters on cell-surface
whereas most of them display distinct nano-clusters equivalent to
1–4 QD-bound molecules. These findings made it possible to
image nano-spatial re-distribution or re-organization of TCR/
CD3 and CD4 or CD8 co-receptor during T cell activation.
NSOM/QD-based nanoscale imaging directly visualized
CD3 co-clustering or interaction with CD4 co-receptor
Although it has been well accepted that CD4 function as co-
receptor stabilizing MHCp-TCR/CD3 interaction for promoting
TCR signaling, a sustained interaction between TCR/CD3 and
co-receptor for achieving or maintaining full T-cell activation has
not been directly imaged at nanoscale. One of imaging features for
TCR-mediated T cell activation is that TCR/CD3 cluster [32] at
the center of the T-cell/antigen presentation cell (APC) interface
[33,34]. Our recent work has also demonstrated that Ag-specific
cd TCR are nano-clustering to form nano-doamains or micro-
domains during Ag-induced activation of T cells [24]. We
therefore took advantage of TCR/CD3 clustering as a readout
of T cell activation to visualize TCR/CD3 co-clustering or
interaction with CD4 co-receptor after ligation of TCR/CD3 by
anti-CD3 Ab. Interestingly, after the anti-CD3 Ab stimulation of
CD4 T cells, CD3 and CD4 both underwent nano-spatial re-
distribution, clustered and formed well-organized 200–500 nm
nano-domains on cell-surface (Figure S3A, Figure S3B). The
percentages of CD3 and CD4 molecules that arrayed to form
nano-domains increased significantly to 15.464.8% and
20.963.7% from 1.1360.36% and 1.3260.54%, respectively
(Fig. 2, Fig. 3D). The average molecule densities of CD3 and CD4
in nano-domains were 735622/mm
2 and 624630/mm
2, respec-
tively, which were statistically higher than the average density of
CD3 or CD4 clusters observed in un-stimulated T-cells (Fig. 2,
Fig. 3C). Importantly, merge NSOM images showed that CD3
and CD4 were co-clustering within the same nano-domains
(Fig. 2A), suggesting that the TCR/CD3 interaction with CD4 co-
receptor after anti-CD3 Ab stimulation consequently formed co-
clustering nanostructures for sustained T cell activation. Consis-
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detected upon anti-CD3 Ab sitmulation (data not shown).
To determine whether TCR/CD3 interaction or co-clustering
with CD4 co-receptor after T cell interaction is an intrinsic event
specific for TCR/CD3-mediated signaling and activation, CD4 T
cells were stimulated by PMA/Ionomycin (signaling through the
inositol phosphates (IP) pathway not CD3) alone without anti-CD3
Ab co-treatment. PMA/Ionomycin control did not induce visible
CD3–CD4 co-clustering in nano-domains or micro-domains,
although the stimulated T cells got enlarged and developed
independent CD3 or CD4 nano-clusters on the membrane
(Fig. 2B, 3C and Figure S3C, Figure S3D). This was consistent
with the current notion that PMA/Ionomycin induces T-cell
activation by a CD3/TCR-indepedent signaling pathway. Fur-
thermore, to explore the potential mechanism underlying the co-
clustering of CD3 and CD4, we pre-treated the T cells using Lck
inhibitor, 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-
d]pyrimidine(PP2). Interestingly, the PP2 pre-treatment of T cells
greatly reduced the formation of CD4 clusters and CD4/CD3 co-
clusters (Figure S4A), suggesting that tyrosine phosphorylation of
Lck triggers or drives nanoscale co-clustering or interaction
between TCR and co-receptor during CD3-induced T cell
activation. Collectively, for the first time the NSOM/QD-based
system made it possible to directly image CD3 co-clustering or
interaction with CD4 co-receptors in nano-domains or micro-
domains after T cell activation, and such nano-spatial CD3–CD4
co-clustering appeared to be an intrinsic event of TCR/CD3
activation without dependence upon MHC.
CD28 co-stimulation enhanced TCR/CD3 co-clustering
with CD4 in the nano-domains or micro-domains
Although CD28 co-stimulation has been shown to enhance
TCR/CD3-mediated signaling and activation [35,36,37,38,39,40],
the possibility that CD28-enhanced T-cell activation involves a
stronger interaction between TCR/CD3 and CD4 co-receptor has
not been tested. We therefore asked a fundamental question as to
whether CD28 co-stimulation could augment the TCR/CD3
nanoscale co-clustering or interaction with CD4 co-receptor in the
nano-domains, and therefore enhance CD3-induced CD4 T-cell
activation. Thus, CD4 T cells were stimulated with both anti-CD3
Ab and anti-CD28 Ab, and imaged for magnitudes of CD3-CD4
co-clusteringinnano-domainsormicro-domains.Surprisingly,anti-
CD28 Ab co-stimulation remarkably increased anti-CD3 Ab-
induced CD3-CD4 co-clustering or interaction, as fluorescence
size and density of CD3 and CD4 clusters or CD3-CD4 co-clusters
in the co-localized nano-domains and micro-domains were
apparently greater than those induced by anti-CD3 Ab stimulation
alone (Figs. 3A, 3C, 3D, Figure S5A, Figure S5B). The average
molecule densities of CD3 and CD4 in nano- or micro-domains of
co-stimulated T cells were 1230631/mm
2 and 987626/mm
2,
respectively, which was statistically significant greater than those
of the anti-CD3-stimulated T-cells (Fig. 3C). The CD28 co-
Figure 1. The NSOM/QD-based two-color imaging showed that about 6–10% of CD3 were co-clustering with CD4 or CD8 as 70–110
nm nano-clusters. Upper panels in each of the sub-figures show fluorescence images of a whole cell; Middle panels show zoom images of the areas
as indicated by the squares on the top panels. Lower panels show the T cell topography and topography-fluorescence overlay images. Scale bars are
indicated in each sub-figure. The integration time for all the images was 30 ms with 400*400 scanning lines. (A) NSOM/QD-based two-color images of
one representative of the un-stimulated CD4 T-cells. Majority of CD3 and CD4 were distinctly distributed on the membrane; about 6–10% of CD3
were co-localizing with CD4 as 80–100 nm nanoclusters. Of note, these co-localized nanoclusters did not form nano- or micro-domains. (B) NSOM/
QD-based two-color images of one representative of the un-stimulated CD8 T-cells. The nanoscale distribution pattern was similar to what was seen
for CD4 T cells.
doi:10.1371/journal.pone.0005945.g001
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with the co-stimulation-mediated increases in expression of IL-2 by
CD3 Ab-activated T cells (data not shown here). Interestingly, even
though a fraction of CD4 did not co-localize with CD3 in
nanodomains/microdomains, they intended to localize themselves
close to CD3 (as shown by the yellow arrow heads in Fig. 3A),
possibly reflecting CD4 trafficking into and out of TCR/CD3
complex during sustained T-cell activation. In contrast, anti-CD28
Ab stimulation alone did not induce nano-spatial CD3-CD4 co-
clustering or interaction (Fig. 3B, Figure S5C, Figure S5D). Thus,
these results provided evidence demonstrating that CD28 co-
stimulation remarkably enhanced TCR/CD3 co-clustering or
interaction with CD4 in the nano-domains or micro-domains on
the cell membrane of the anti-CD3 Ab-activated CD4 T cells.
TCR/CD3 ligation also induced CD3 co-clustering with
CD8 in well-organized nano-domains of activated CD8 T
cells; CD28 co-stimulation did not enhance CD8
clustering or CD3-CD8 co-clustering in nano-domains
Although both CD4 and CD8 function as co-receptors during
T-cell signaling and activation, accumulating evidence suggests
that CD8 may differ from CD4 in facilitating T-cell signaling and
activation [41,42,43]. From the nanosclae imaging standpoint, we
sought to determine whether TCR/CD3 ligation also led to CD3-
CD8 co-clustering in the same nano- or micro-domains, and
whether CD28 co-activation could also enhance CD3-CD8 co-
clustering as seen for CD3-CD4 co-clustering. After anti-CD3 Ab
stimulation of CD8 T cells, ,65% of CD3 and CD8 molecules
underwent nano-spatial re-distribution to array and cluster
forming nano-domains (Fig. 4A, 4D, Figure S6A, Figure S6B).
Such re-distribution and clustering led to increase molecular
density in the CD3 and CD8 nano-domains, respectively, although
CD8 nano-domains were smaller and less dense than CD3 nano-
domains (Fig. 4A). The overlay NSOM images indicated that the
TCR ligation indeed also induced CD3 co-clustering with CD8
co-receptor, despite that CD3 was much more dominant than
CD8 in the same nano- or micro-domains after TCR/CD3
ligation (Fig. 4A). It was noted that co-clustering of CD3/CD8
induced by anti-CD3 simulation was abrogated significantly by
pre-treatment of T cell by LCK inhibitor, PP2 (Supporting
information, Figure S4B).
Surprisingly, CD28 co-stimulation did not enhance CD8
clustering or CD3-CD8 co-clustering in nano-domains (Fig. 4B,
Figure S6C, Figure S6D), although it increased molecular number
and density of CD3 clustering in enlarged nano-domains. After
anti-CD3 and anti-CD28 co-stimulation, the average molecule
density of CD3 increased to 1085631/mm
2, which was much
higher than that observed in the T cells stimulated with the anti-
CD3 alone (Fig. 4B, 4C, p,0.05). Since CD28 on CD8+ T cells
Figure 2. NSOM/QD-based nanoscale two-color imaging directly imaged CD3 co-clustering or interaction with CD4 co-receptor
after activation of CD4 T cells by anti-CD3 Ab. The integration time for all the images was 30 ms with 400*400 scanning lines. (A) The NSOM
dual color images of one representative of the anti-CD3 Ab-stimulated T-cells. The upper (whole-cell images) and middle (zoom images) panels show
nano-clustering of CD3 (dark blue) and CD4 (red) as well as co-clustering of CD3-CD4 (overlay pink) forming nano-domains or micro-domains on cell
surface of an activated T-cell, as illustrated by white arrows. Note that CD3, CD4 or CD3–CD4 nano-domains were hardly seen in un-stimulated T cells.
The activated CD4 T cells also had a number of CD3–CD4 co-localized nano-clusters 70–110 nm outside the nano-domains as illustrated by yellow
arrows. Lower panels show the T cell topography and topography-fluorescence overlay images. (B) The NSOM dual-color images of one
representative of the PMA/Ionomycin-stimulated T-cells. Note that although PMA/Ionomycin stimulation led to the formation of independent CD3 or
CD4 nano-domains, there was no apparent co-clustering or co-localization of CD3 and CD4 in the nano-domains on the membrane of PMA/
Ionomycin-stimulated T-cells. Lower panels show the T cell topography and topography-fluorescence overlay images.
doi:10.1371/journal.pone.0005945.g002
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5945Figure 3. CD28 co-activation remarkably enhanced TCR/CD3 co-clustering or interaction with CD4 on the cell membrane of the
anti-CD3 Ab-activated CD4 T cells. (A) The NSOM dual color images of one representative of the T-cells co-stimulated with anti-CD3 Ab and anti-
CD28 Ab. The CD28 co-stimulation led to marked increases in numbers of CD3-CD4 co-clustering nano-domains or micro-domains (upper panel) as
well as in the density and size (middle panel) of co-localized CD3 and CD4 nano-domains or micro-domains compared to the anti-CD3 Ab alone
(Fig. 2A). Lower panels show the T cell topography and topography-fluorescence overlay images. Note that complete co-clustering of CD3 and CD4
took place in the central areas of nano-domains or micro-domains, leaving only small numbers of CD3-only or CD4-only clusters in the peripheral
area. CD28 co-stimulation led to increases in secretion of IL-2 by CD3 Ab-activated T cells (data not shown here). (B) The NSOM dual-color images of
one representative of the anti-CD28 Ab alone-stimulated T-cells. Note that anti-CD28 Ab stimulation led to the formation of few independent CD3 or
CD4 nano-domains, but there was no apparent co-clustering or co-localization of CD3 and CD4 in the nano-domains on the membrane. Lower panels
show the T cell topography and topography-fluorescence overlay images. (C) Molecular-density analysis shows the molecular density of CD3 or CD4
molecules on the membrane of un-stimulated T cells, T cells stimulated with anti-CD28 Ab only, anti-CD3 Ab only and T cells co-stimulated with anti-
CD3 Ab and anti-CD28 Ab. Anti-CD3 Ab-stimulated T cells exhibited significantly-greater molecular density of CD3 or CD4 compared to unstimulated
T-cell, PMA/Ionomycin-stimulated T-cells or anti-CD28 Ab only-stimulated T cells (p,0.05); Anti-CD28/anti-CD3 Ab co-stimulation significantly
increases density of co-localized CD3–CD4 nano- or micro-domains (p,0.05) compared to anti-CD3 Ab stimulation only. Similar results were observed
regardless of whether CD3 and CD4 were stained with QD605 or QD655. Up to 10 cells were analyzed. (D) Molecular-number analysis shows the
percentages of total CD3 or CD4 molecules that arrayed to form nano- or micro-domains on the membrane of un-stimulated T cells, T cells stimulated
with anti-CD28 Ab only, anti-CD3 Ab only and T cells co-stimulated with anti-CD3 Ab and anti-CD28 Ab. Anti-CD3 Ab-stimulated T cells exhibited
significantly higher numbers of CD3 or CD4 nano-domains and co-localized CD3–CD4 nanodomains compared to unstimulated T cells, PMA/
Ionomycin-stimulated T-cells or anti-CD28 Ab only-stimulated T cells (p,0.05); Anti-CD28/anti-CD3 Ab co-stimulation significantly increases numbers
of co-localized CD3–CD4 nano- or micro-domains (p,0.05) compared to anti-CD3 Ab stimulation only. Up to 10 cells were analyzed.
doi:10.1371/journal.pone.0005945.g003
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PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e5945Figure 4. TCR/CD3 ligation also induced CD3 co-clustering with CD8 in well-organized nano- or micro-domains of activated CD8 T
cells; CD28 co-stimulation did not enhance CD8 clustering or CD3-CD8 co-clustering in nano-domains. The scale bar for the middle
panel is 200 nm. The integration time for all the images was 30 ms with 400*400 scanning lines. (A) The NSOM dual color images of one
representative of the anti-CD3 Ab-stimulated CD8 T-cells. Note that both CD3 and CD8 formed nano-domains that were hardly seen in un-stimulated
T cells. Nano-spatial co-clustering or co-localization of CD3 and CD8 (overlay pink color) was also seen in these nano-domains. Lower panels show the
T cell topography and topography-fluorescence overlay images. (B) The NSOM dual color images of one representative of the CD8 T-cells co-
stimulated with anti-CD3 Ab and anti-CD28 Ab. Note that CD28 co-stimulation did not enhance CD8 clustering or CD3-CD8 co-clustering in nano-
domains, although it increased molecular number and density of CD3 clustering in enlarged nano-domains. Lower panels show the T cell topography
and topography-fluorescence overlay images. (C) Molecular-density analysis shows that anti-CD3 Ab-stimulated CD8 T cells exhibited significantly-
greater molecular density of CD3 or CD8 in the nano- or micro-domains compared to un-stimulated T cells, PMA/Ionomycin-stimulated T-cells or anti-
Nanoimaging of T Cells
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absence of significant CD3-CD8 co-clustering upon CD28 co-
stimulation did not appear to be attributed to no or less expression
of CD28 on CD8+ T cells. Consistently, the CD28 co-stimulation
led to increased expression of IFN-c by CD3 Ab-activated T cells
(data not shown here). In contrast, the density of CD8 was only
482621/mm
2, quite similar to what was seen in the CD8 T cells
activated with ant-CD3 Ab alone. Almost 3 CD3 versus 1 CD8 co-
clustered together in each of the co-localized nano- or micro-
domains after CD28 co-stimulation (Fig. 4D). In fact, the
percentage of CD8 recruited to the nano- or micro-domains and
CD8 molecular density in the nano- or micro-domains were much
lower than their CD4 counterparts after anti-CD3 Ab and anti-
CD28 Ab co-stimulation (Fig. 4E, 4F, p,0.05). It is also worth to
point out that no CD3 co-clustering with CD8 in nano- or micro-
domains in the membrane of T cells activated by anti-CD28 Ab
alone or PMA/Ionomycin alone (Supplemental information,
Figure S7Ai, Figure S7Aii, Figure S7Aiii, Figure S7Bi, Figure
S7Bii, Figure S7Biii). Thus, similar to what was seen for CD4 T
cells, TCR/CD3 ligation induced CD3 co-clustering with CD8 in
well-organized nano- or micro-domains of activated CD8 T cells.
However, CD28 co-stimulation did not enhance CD8 clustering
or CD3-CD8 co-clustering in nano-domains although it increased
molecular number and density of CD3 clustering in enlarged
nano-domains.
Discussion
The NSOM/QD-based imaging system directly images the
nano-spatial relationship between TCR/CD3 and CD4 or CD8
co-receptor before and after activation of un-stimulated primary T
cells. While flow cytometry, fluorescence and confocal mircoscapy
show high-density, un-distinguished ‘‘dispersed caps’’ of TCR/
CD3 [24], CD4 or CD8 on membrane of resting/un-stimulated
ab T cells, there is actually no nanoscale information conceiving
whether and how each of these major molecules distribute and
share nano-space on membrane. Now, the NSOM/QD-based
nanoscale imaging system allows us to directly visualize distribu-
tion and organization of these molecules on T-cell membrane,
since the NSOM/QD-based imaging is highly reproducible, with
up to 10
4 TCR/cell detectable [24]. To our surprise, only about
5–8% of CD3 receptor and CD4 or 10% CD8 co-receptor were
expressed as single QD-bound molecules on membrane. Using the
standard staining reagents and protocol [1:1 dominant binding
mode for Ab/streptavidin binding to ligand] [24], single QD
fluorescence dots would be considered one or more than one CD3,
CD4 or CD8 molecules. Most of CD3, CD4 or CD8 on
membrane are clusters equivalent to two more QD fluorescence
intensity. While these low-density nanoclusters may represent
natural random distribution patterns or the pre-clustering of
CD3/TCR [31], they might be caused by some uncontrolled
factors such as thermic shock or isolation procedures. However,
$40–50 nm nanospace conferring distinction among CD3
molecules or between CD3 and CD4 or CD8 co-receptor is
clearly seen under the NSOM. NSOM/QD-based imaging
appears to confer better resolution imaging for horizontal scanning
of cell-surface molecules than total internal reflection fluorescence
(TIRF) microscopy, although the latter is advantageous for real
time dynamics [34,44,45,46].
The nanoscale CD3 co-clustering with CD4 or CD8 in the co-
localized nano-domains or micro-domains during CD3-induced
and CD28-enhanced T cell activation may represent interaction
between TCR/CD3 and CD4 or CD8 co-receptor. These co-
clustering CD3 and CD4 or CD8 molecules are at least ,40–
50 nm proximity to each other in the clusters of nano-domains, as
NSOM is capable to measure molecule sizes down to ,50 nm
[24] and to spatially resolve molecules that are of 40–50 nm
distance. The nanoscale co-clustering of CD3 and CD4 or CD8
not only occurs and but also forms the co-localized nano- or
micro-domains in the sustained T cell activation. Such nanoscale
co-clustering or interaction between CD3 and CD4 or CD8 co-
receptor is an active process linked to TCR/CD3 activation
pathway rather than a passive event simply caused by activation-
induced changes in cellular skeleton [47]. This notion is supported
by the finding that PMA/Ionomycin-induced activation or CD28
Ab alone stimulation does not induce CD3 co-clustering with CD4
or CD8 co-receptor. In addition, CD28-enhanced activation after
anti-CD28 Ab co-stimulation induces greater CD3-CD4 co-
clustering in the nano- or micro-domains but leaves no changes
in CD8 co-clustering in the co-localized nano- or micro-domains.
In fact, the nanoscale CD3 co-clustering with CD4 or CD8 in the
co-localized nano-domains or micro-domains during sustained T
cell activation is consistent with what is reported in biochemical
studies suggesting that CD3 delta chains could establish a
functional link with CD8 [14]. And this is also in agreement with
FRET studies of transient CD3-CD4 or CD3-CD8 interaction in
transfected T hybridoma cells [15,48], but not in agreement with
the report suggesting that CD4 initially co-localize with CD3 after
TCR ligation but subsequently depart away from the CD3 cluster
in single-molecule transfected cell model [11]. It is worth to
mention that our current work focuses on nano-spatial aspects of
CD3 co-clustering with co-receptor during sustained activation of
primary CD4 and CD8 T cells after CD3 signaling and CD3/
CD28 co-signaling, therefore complements the finding seen in
CD3 and/or CD4/CD8 transfected cell models [11,15,48].
Our NSOM/QD imaging data suggest that nanoscale interac-
tion between TCR/CD3 and CD4 or CD8 co-receptor is not
purely a MHCp-dependent process, but also can be induced by
the TCR/CD3 activation pathway itself and be driven by tyrosine
phosphorylation of Lck. CD3 Ab-induced activation appears to
drive the nanoscale co-clustering or interaction between CD3 and
CD4 or CD8 co-receptor in the co-localized nano- or micro-
domains. This intrinsic capability of TCR/CD3 activation
pathway suggests that once TCR/CD3 activation is initiated, it
may positively feedback and enhance Lck-dependent recruitment
of CD4 or CD8 co-receptor for sustaining TCR/CD3-induced T
CD28 Ab only-stimulated T cells (p,0.05); Anti-CD28/anti-CD3 Ab co-stimulation significantly increases density of CD3 (p,0.05), but CD8 remains
almost the same in the co-localized nano- or micro-domains compared to anti-CD3 Ab stimulation only. Up to 10 cells were analyzed. (D) Molecular-
number analysis shows that anti-CD3 Ab-stimulated CD8 T cells exhibited significantly-greater percentage numbers of total CD3 or CD8 molecules
that arrayed to form nano- or micro-domains compared to un-stimulated T cells, PMA/Ionomycin-stimulated T-cells or anti-CD28 Ab only-stimulated T
cells (p,0.05); Anti-CD28/anti-CD3 Ab co-stimulation significantly increases numbers of CD3 (p,0.05), but co-localized CD8 remains almost the same
in the co-localized nano- or micro-domains compared to anti-CD3 Ab stimulation only. Up to 10 cells were analyzed. Similar results were observed
regardless of whether CD3 and CD8 were stained with QD605 or QD655. (E) Molecule density of CD4 in the nano- or micro-domains in the CD4 T cells
co-stimulated with anti-CD3 and anti-CD28 Ab was much greater than CD8 in the CD8 T cells co-stimulated similarly (** indicates p,0.05). Up to 10
cells were analyzed. (F)The percentage numbers of CD4 molecules that arrayed to form nano- or micro-domains in the CD4 T cells co-stimulated with
anti-CD3 and anti-CD28 Ab was much higher than CD8 in the CD8 T cells co-stimulated similarly (* indicates p,0.05). Up to 10 cells were analyzed.
doi:10.1371/journal.pone.0005945.g004
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CD8 co-receptor are recruited by TCR/CD3, the more
phosphorylation of Lck-ZAP70 would be induced to amplify
TCR/CD3 activation pathway.
One of the new and interesting observations in the current study
is that CD28 co-stimulation can clearly enhance nanoscale co-
clustering of CD3 with CD4 but not CD8, and form greater size
and density of CD3-CD4-co-clustered nano-domains or micro-
domains. While most studies done to date have showed that CD28
co-stimulation increases TCR/CD3 signaling and promote full T
cell activation [49,50,51], the possibility that CD28-mediated
enhancement of TCR/CD3 signaling and activation involves the
augmented CD3 interaction with CD4 has not been addressed.
Our NSOM/QD imaging data clearly show that CD28 co-
activation enhances nanoscale co-clustering of CD3 and CD4 and
augments CD3-induced T cell activation, which is characterized
by increases in molecular density and sizes of co-clustering CD3
and CD4 nano-domains or micro-domains. These data suggest
that CD28 co-signaling-enhanced T cell activation may involve
the augmentation of CD3-CD4 interaction. It would be interesting
to determine whether CD28-enhanced CD3-CD4 interaction
involves T-cell cytoskeletal rearrangements [52]. It is also worth to
note that CD28 co-stimulation has been shown to increase
tyrosine phosphorylation of substrates and consumption of Lck
[50,53]. The increased tyrosine phosphorylation and Lck
consumption after CD28 co-stimulation can be explained here
by the CD28 co-stimulation-enhanced co-clustering of CD3 and
CD4 in nanodoamins, as the increased co-clustering or interaction
after CD28 co-activation would enable more CD4-associated Lck
to proximate CD3 for ZAP70 phosphorylation and cellular
activation.
Another interesting finding from our NSOM/QD imaging
studies is the demonstration of a different nanoscale co-clustering
pattern for CD3 and CD8 compared to CD3 and CD4
interaction. While CD3 Ab-induced activation leads to nanoscale
co-clustering of CD3 and CD4 or CD3 and CD8 in nano- or
micro-domains, CD8 clustering and CD3-CD8 co-clustering
appear to be less dramatic than CD4 clustering and CD3-CD4
co-clustering, respectively (Fig. 2A, Fig. 4A, 4C, 4D). More
importantly, CD28 co-stimulation does not enhance CD8
clustering or CD3-CD8 co-clustering in nano-domains. This is
quite contrasted to the CD28 co-stimulation-mediated enhance-
ment of CD4 clustering and CD3-CD4 co-clustering in enlarged
nano-domains or micro-domains. Nevertheless, CD28 co-stimu-
lation appears to enhance CD8 T cell activation as there are
notable increases in sizes and density of nanoscale CD3 clustering
and CD3-predominant nano-domains or micro-domains on
membrane of CD8 T cells co-stimulated with anti-CD3 and
anti-CD28 Ab. From a functional standpoint, these results suggest
that CD8 may be more efficient than CD4 in facilitating CD3-
induced signaling and activation after TCR ligation and anti-CD3
Ab and anti-CD28 Ab co-engagement. This is consistent with the
reports describing that CD8+ T cells require much fewer MHCp
molecules than CD4+ T cells do for full activation of T-cells
[54,55]. On the other hand, the data may reflect the structure
constraint for CD8-Lck-CD3 association, as Lck prefers to bind to
CD4 than CD8 [56].
Materials and Methods
Animals and reagents
Three Rhesus (Macaca macutum) macaques without any
treatment or vaccination, 4 to 8 years old, (3–5 kg weight) were
used for collection and isolation of T-cells from blood. The animal
use was approved by UIC IACUC. Anti-CD3-coated or anti-
CD3/anti-CD28-coated 96-well plates were from BD Biosciences.
RPMI-1640 culture medium was obtained from GibcoBRL Corp.
Rabbit anti-human CD3 was from Dako. Mouse anti-human CD4
or CD8 antibody were from BD Pharmagin. Biotinylated anti-
mouse IgG was from Invitrogen. PMA and Ionomycin were from
Sigma. Lck inhibitor PP2 was from Calbiochem. Anti-rabbit IgG
(H+L)-conjugated quantum dot (QD) 605 and streptavidin-
conjugated QD 655 were from Invitrogen as well. QDs were
centrifuged and filtered as previously described to remove
aggregates of QDs [24]. All these antibodies and QDs have been
validated for use at our lab [24,57,58].
Lymphocyte isolation, T-cell stimulation, and immune
staining
Peripheral blood was collected from Rhesus monkeys as
described above. Peripheral blood mononuclear cells (PBMC)
were separated by Ficoll-Hypaque gradient centrifugation and
washed with phosphate-buffered saline (PBS) as described by the
previous reports of our lab [57]. For the anti-CD3 Ab stimulation,
PBMC at a cell density of 2610
5 cells/ml were seeded into anti-
CD3 Ab-coated 96-well plates for 8-hours culture in RPMI 1640
containing 10% FBS at 37uC in a 5% CO2 atmosphere. For the
anti-CD3/anti-CD28 Ab co-stimulation, PBMC at a cell density
of 2610
5 cells/ml were seeded onto anti-CD3 Ab-coated 96-well
plates and co-cultured with 5 ng/ml anti-CD28 Ab for eight hours
in RPMI 1640 containing 10% FBS at 37uC in a 5% CO2
atmosphere. For anti-CD28 Ab only stimulation, PBMC at a cell
density of 2610
5 cells/ml were seeded into 96-well plates and co-
cultured with 5 ng/ml anti-CD28 for eight hours in RPMI 1640
containing 10% FBS at 37uC in a 5% CO2 atmosphere. For
PMA/Ionomycin stimulation, PBMC at a cell density of
2610
5 cells/ml were seeded into 96-well plates and co-cultured
with 10 ng/ml PMA and 1 m Ionomycin for 8-hours in RPMI
1640 containing 10% FBS at 37uC in a 5% CO2 atmosphere. To
determine if tyrosine phospholation of Lck involved the intrinsic
CD3 co-clustering with CD4 or CD8, T cells were pre-treated for
30 minutes with Lck inhibitor PP2 (0.1 mg/ml), and then were
stimulated with anti-CD3 Ab as decribed above.
For T-cell immunolabeling, 2% formalin/PBS solution was first
used to fix T-cells for 20 mins to rule out the possibility of non-
specific activation of T-cells which induced by antibody labeling
[24]. Our repeated experiments showed that formalin fixation
followed by antibody staining did not induce artificial nanos-
tructures of T cells (data not shown). In the first color labeling,
purified mouse anti-human CD4 or CD8 antibody were used to
label corresponding molecules, respectively, followed by biotiny-
lated anti-mouse IgG conjugate to CD4 or CD8 antibody, then
QD streptavidin conjugated 655 to conjugate to IgG. In the
second color labeling, rabbit anti-human CD3 was used to label
CD3, followed by anti-rabbit QD IgG (H+L) conjugated 605.
Finally, 2% formalin/PBS solution was used again to further fix
the cells. For all of above each labeling step, FBS/PBS was applied
to wash twice to remove any unbound antibody or QDs. For
NSOM imaging study, dd water suspensions of cells were spread
onto glass cover slides that were pretreated with poly-L-lysine
(Sigma) and air-dried at room temperature for NSOM imaging.
Non-specific staining was not seen under the NSOM for the
controls using isotype control antibody followed by immune-
conjugated QD or QD alone, as described previously [24]. Non-
specific staining was not seen either when anti-human TCR Ab
was used to stain mouse T cells (data not shown). Ab- or
streptavidin-conjugated QD appear to have sizes of <25 nm [24].
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,10 nm and ,5–8 nm respectively).
NSOM imaging and polarization detection
An Aurora-3 NSOM system (Veeco) was used in this study. The
system is shown schematically in our pervious study [25]. The
continuous wave semiconductor laser (Coherent, USA; Cube,
404 nm) was launched into a single mode optical fiber (Thorlabs
Inc, USA) and used as excitation source. Straight, aluminum -
coated probe (Veeco) with an aperture diameter of 50–80 nm was
used for imaging. It should be noted that no significant difference in
full width at the half maximum (FWHM) of fluorescent spots when
we used different probes [24]. The probe tip was attached to
piezoelectric quartz tuning fork (resonance frequency ,93 KHz),
and probe-sample distance was maintained constant of 10
nanometers by tuning-fork-based shear-force feedback. This mode
of operation provided simultaneous topographic and optical data,
which was collected with a 406, NA 0.65 objective (Olympus,
Japan) and split into two beams by a polarizing cube beamsplitter
(Newports Inc. USA), then detected by two APDs (PerkinElmer,
Canada) in 0u and 90u, respectively. Optical filters 655610 nm and
605610 nm (Newports Inc. USA) were used to separate the
fluorescence from the excitation light and the background. The
samples were mounted onto the XY stage with full scanning range
of 30 micro;m630 mm, and a video camera was used to locate the
regions of interested. The images were stable and reproducible
during repeated scanning. In this study, the laser excitationintensity
was 120 W/cm
2, the images consisted of 4006400 measured
points, and most images have been slightly low-pass filtered.
Image processing, data analyses and statistics
SPMLab 6.02 software (Veeco) was used to obtain high quality
NSOM fluorescence image by leveling and convolution. The color
scale ranges from red to green, reflecting a 90u change in in-plane
orientation. Mathlab7.0 were used to calculate the fluorescence
intensity and measure FWHM distribution of fluorescent spots.
The number of QD molecules in each fluorescence spot was
estimated based on the fluorescence intensity of single QD (see
below), wheareas the intensity of each spot was determined by
adding all photon counts with a contour of 15% of the peak
intensity. For the molecular density determination, the fluores-
cence intensity of fluorescent spots was analyzed to determine the
average fluorescence signal representing the average QD numbers.
At the excitation laser intensity of 120 W/mm
2, a typical count
rate for individual QD 655 and QD605 were <7,000 counts/
second and <4,500 counts/second, respectively (these values were
reproducible in repeat experiments). And then the QD numbers
were used to correlate the molecule numbers based on the
conservative assumption that the QD: secondary Ab: primary Ab:
target molecule=1:1:1:1 [24,25]. And then the molecular density
was determined by dividing the molecule numbers over the nano-
or micro-domains areas. Student t-test was used to calculate the p-
value, as described previously [59], to determine the statistical
difference of molecular density or the percentages of molecules
that localized into nano- or micro- domains after different
stimulations.
Supporting Information
Figure S1 The NSOM/QD-based polarized imaging system
indicated that CD3, CD4 or CD8 molecules were distinctly
distributed as single QD-bound molecules or nano-clusters
equivalent to two or more QD fluorescence intensity on cell-
membrane of un-stimulated primary T cells For the NSOM/QD-
based polarized imaging system, the fluorescence emission is split
into two images with orthogonal polarization components by using
a polarization-beam splitter (PBS). The red images are for parallel
polarization component (0u); the green images are for vertical
polarization component (90u). Upper panels in each of the sub-
figures show fluorescence images of a whole cell; Middle panels
show zoom images of the areas as indicated by the squares on the
top panels. Lower panels show the T cell topography and
topography-fluorescence overlay images. Scale bars are indicated
in each sub-figure. The integration time for all the images was
30ms with 400*400 scanning lines. (Ai) Nanoscale polarized CD3
images of one representative of the un-stimulated CD4 T-cells.
Note that only about 5–8% of CD3 were distributed as single-QD-
bound molecules (illustrated by red or green circulated dots) since
these individual QD dots were equivalent to fluorescence intensity
and FWHM of one QD spot and detectable on either horizontal
[red, (0u)] or vertical [green, (90u)] polarization component. The
majority of QD-bound CD3 molecules were imaged in both 0u
and 90u polarization components [yellow] and distributed as nano-
clusters equivalent to two or more QD fluorescence intensity/
FWHM on the cell-surface. (Aii) Two histograms show frequency
distribution of fluorescence intensity (upper panel) and size
(FWHM) (lower panel) of QD-bound CD3 on membrane of ten
T cells. Single or multiple QD-bound CD3 were judged based on
the single QD fluorescence intensity and size (FWHM) as
previously published [1] as well as polarization detection. (Bi)
Nanoscale polarized CD4 images of one representative of the un-
stimulated CD4 T-cells. Legends are the same as Fig. 1A. About
5–8% of CD4 were truly single-QD-bound molecules, whereas
majority of them were nano-clusters equivalent to two or more
QD fluorescence intensity and FWHM. (Bii) Two histograms show
frequency distribution of fluorescence intensity (upper panel) and
size (FWHM) (lower panel) of QD-bound CD4 on membrane of
ten T cells. (Ci) Nanoscale polarized CD8 images of one
representative of the un-stimulated CD8 T-cells. Unlike CD3 or
CD4, a little bid more than 10% of CD8 was single-QD-bound
molecules, whereas others were nano-clusters equivalent to two or
more QD fluorescence intensity and FWHM. (Cii) Two
histograms show frequency distribution of fluorescence intensity
(upper panel) and size (FWHM) (lower panel) of QD-bound CD8
on membrane of ten T cells. (D)NSOM/QD-based imaging
suggested that no significant fluorescence was observed on T cells
when we used QD-streptavidin only to stain cells. (E) NSOM/
QD-based imaging suggested that no significant fluorescence was
observed on T cells when we used antibody only to stain cells.
References: 1. Zeng G, Chen J, Zhong L, Wang R, Jiang L, et al.
(2009) NSOM- and AFM-based nanotechnology elucidates nano-
structural and atomic-force features of a Y. pestis V immunogen-
containing particle vaccine capable of eliciting robust response.
Proteomics 9: 1538–1547.
Found at: doi:10.1371/journal.pone.0005945.s001 (1.73 MB
DOC)
Figure S2 (A) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD3 on membrane of ten resting CD4 T cells. (B) Two
histograms show frequency distribution of fluorescence intensity (left
panel) and size (FWHM) (right panel) of QD-bound CD4 on
membrane of ten resting CD4 T cells. (C) Two histograms show
frequency distribution of fluorescence intensity (left panel) and size
(FWHM) (right panel) of QD-bound CD3 on membrane of ten
resting CD8 T cells. (D) Two histograms show frequency distribution
of fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD8 on membrane of ten resting CD8 T cells.
Found at: doi:10.1371/journal.pone.0005945.s002 (0.06 MB PPT)
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fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD3 on membrane of ten anti-CD3 Ab-stimulated
CD4 T cells. (B) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD4 on membrane of ten anti-CD3 Ab-stimulated
CD4 T cells. (C) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD3 on membrane of ten PMA/Ionomycin-stimulat-
ed CD4 T cells. (D) Two histograms show frequency distribution
of fluorescence intensity (left panel) and size (FWHM) (right panel)
of QD-bound CD4 on membrane of ten PMA/Ionomycin-
stimulated CD4 T cells.
Found at: doi:10.1371/journal.pone.0005945.s003 (0.07 MB PPT)
Figure S4 Lck inhibition significantly inhibited the cluster
formation of CD4(A) and CD8(B), respectively. The Lck inhibition
was done by pre-treatment of T-cells with Lck inhibitor PP2 for 30
minutes. And these T-cells were stimulated with anti-CD3
antibody. Note that no significant clusters were observed for
CD4 and CD8, respectively.
Found at: doi:10.1371/journal.pone.0005945.s004 (1.33 MB PPT)
Figure S5 (A) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD3 on membrane of anti-CD3/anti-CD28 co-
stimulated CD4 T cells. (B) Two histograms show frequency
distribution of fluorescence intensity (left panel) and size (FWHM)
(right panel) of QD-bound CD4 on membrane of anti-CD3/anti-
CD28 co-stimulated CD4 T cells. (C) Two histograms show
frequency distribution of fluorescence intensity (left panel) and size
(FWHM) (right panel) of QD-bound CD3 on membrane of ten
anti-CD28-stimulated CD4 T cells. (D) Two histograms show
frequency distribution of fluorescence intensity (left panel) and size
(FWHM) (right panel) of QD-bound CD4 on membrane of ten
anti-CD28-stimulated CD4 T cells.
Found at: doi:10.1371/journal.pone.0005945.s005 (0.06 MB PPT)
Figure S6 (A) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD3 on membrane of anti-CD3 co-stimulated CD8 T
cells. (B) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel)
of QD-bound CD8 on membrane of anti-CD3-stimulated CD8 T
cells. (C) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel)
of QD-bound CD3 on membrane of ten a anti-CD3/anti-CD28
co-stimulated CD8 T cells. (D) Two histograms show frequency
distribution of fluorescence intensity (left panel) and size (FWHM)
(right panel) of QD-bound CD8 on membrane of ten anti-CD3/
anti-CD28 co-stimulated CD8 T cells.
Found at: doi:10.1371/journal.pone.0005945.s006 (0.06 MB PPT)
Figure S7 The NSOM dual-color images show that CD28 co-
stimulation or PMA/Ionomycin stimulation did not enhance CD8
clustering or CD3-CD8 co-clustering in nano-domains (A) The
NSOM dual-color images of one representative of the anti-CD28
Ab only-stimulated T-cells. Anti-CD28 Ab stimulation alone did
not enhance CD8 clustering or CD3-CD8 co-clustering in nano-
domains, although it increased molecular number and density of
CD3 clustering and enlarged nano-domains. Lower panels show
the T cell topography and topography-fluorescence overlay
images. (B) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel)
of QD-bound CD3 on membrane of anti-CD28-stimulated CD8
T cells. (C) Two histograms show frequency distribution of
fluorescence intensity (left panel) and size (FWHM) (right panel) of
QD-bound CD8 on membrane of anti-CD28-stimulated CD8 T
cells. (D) The NSOMdual-color images of one representative of
the PMA/Ionomycin-stimulated T-cells. PMA/Ionomycin stimu-
lation did not induce apparent co-localized CD3 and CD8 nano-
or micro-domains on the membrane of PMA/Ionomycin-
stimulated CD8 T-cells. Lower panels show the T cell topography
and topography-fluorescence overlay images. (E) Two histograms
show frequency distribution of fluorescence intensity (left panel)
and size (FWHM) (right panel) of QD-bound CD3 on membrane
of PMA/Ionomycin-stimulated CD8 T cells. (F) Two histograms
show frequency distribution of fluorescence intensity (left panel)
and size (FWHM) (right panel) of QD-bound CD8 on membrane
of PMA/Ionomycin-stimulated CD8 T cells.
Found at: doi:10.1371/journal.pone.0005945.s007 (0.71 MB PPT)
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